Medifast, Inc. Announces Fourth Quarter and Full Year 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/21/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- Tesla acquires AI hardware company for up to $2 billion in stock
Medifast (MED) Tops Q4 EPS by 26c, Offers Guidance
February 23, 2022 4:56 PM ESTMedifast (NYSE: MED) reported Q4 EPS of $2.91, $0.26 better than the analyst estimate of $2.65. Revenue for the quarter came in at $377.8 million versus the consensus estimate of $375.79 million.
GUIDANCE:
Medifast sees FY2022 EPS of $14.50-$16.00, versus the consensus of $15.96. Medifast sees... More
